T Ishimori

Author PubWeight™ 39.13‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Scrotal disorders: evaluation of testicular enhancement patterns at dynamic contrast-enhanced subtraction MR imaging. Radiology 2000 1.86
2 Dynamic subtraction contrast-enhanced MR angiography: technique, clinical applications, and pitfalls. Radiographics 2000 1.63
3 Establishment and characterization of a breast cancer cell line expressing Na+/I- symporters for radioiodide concentrator gene therapy. J Nucl Med 2000 1.59
4 Clinical value of positron emission tomography with FDG for recurrent ovarian cancer. AJR Am J Roentgenol 2001 1.59
5 The clinical significance of exercise-induced ST-segment elevation. Circulation 1976 1.54
6 A better control for ICD patients? Eur Heart J 2002 1.39
7 Myocardial bridges in man: clinical correlations and angiographic accentuation with nitroglycerin. Cathet Cardiovasc Diagn 1977 1.36
8 Value and safety of cardiac catheterization during active infective endocarditis. Am J Cardiol 1979 1.28
9 The incidence and clinical implications of coronary artery spasm. Circulation 1975 1.24
10 Clinical correlates of left ventricular cavity obliteration. Am J Cardiol 1977 1.14
11 Provocation of coronary artery spasm by the cold pressor test. Hemodynamic, arteriographic and quantitative angiographic observations. Circulation 1980 1.09
12 Echocardiographic, haemodynamic, and angiographic correlations in hypertrophic cardiomyopathy. Br Heart J 1977 1.05
13 Pseudo-obstruction of the extrahepatic bile duct due to artifact from arterial pulsatile compression: a diagnostic pitfall of MR cholangiopancreatography. Radiology 2000 1.01
14 Novel liver macromolecular MR contrast agent with a polypropylenimine diaminobutyl dendrimer core: comparison to the vascular MR contrast agent with the polyamidoamine dendrimer core. Magn Reson Med 2001 0.96
15 Comparison of the macromolecular MR contrast agents with ethylenediamine-core versus ammonia-core generation-6 polyamidoamine dendrimer. Bioconjug Chem 2001 0.96
16 Tumor targeting and imaging of intraperitoneal tumors by use of antisense oligo-DNA complexed with dendrimers and/or avidin in mice. Clin Cancer Res 2001 0.94
17 Dynamic micro-magnetic resonance imaging of liver micrometastasis in mice with a novel liver macromolecular magnetic resonance contrast agent DAB-Am64-(1B4M-Gd)(64). Cancer Res 2001 0.91
18 3D MR angiography of intratumoral vasculature using a novel macromolecular MR contrast agent. Magn Reson Med 2001 0.90
19 Avidin-dendrimer-(1B4M-Gd)(254): a tumor-targeting therapeutic agent for gadolinium neutron capture therapy of intraperitoneal disseminated tumor which can be monitored by MRI. Bioconjug Chem 2001 0.88
20 Anomalies and anatomic variants of the biliary tree revealed by MR cholangiopancreatography. AJR Am J Roentgenol 1999 0.88
21 Positive effects of polyethylene glycol conjugation to generation-4 polyamidoamine dendrimers as macromolecular MR contrast agents. Magn Reson Med 2001 0.88
22 FDG-PET of autoimmune-related pancreatitis: preliminary results. Eur J Nucl Med 2000 0.88
23 Contrast-enhanced three-dimensional MR portography. Radiographics 1999 0.88
24 Monoclonal antibody-dendrimer conjugates enable radiolabeling of antibody with markedly high specific activity with minimal loss of immunoreactivity. Eur J Nucl Med 2000 0.88
25 Exercise-induced coronary arterial spasm: angiographic demonstration, documentation of ischemia by myocardial scintigraphy and results of pharmacologic intervention. Am J Cardiol 1980 0.87
26 Diagnostic pitfalls of MR cholangiopancreatography in the evaluation of the biliary tract and gallbladder. Radiographics 1999 0.86
27 Hypopituitarism due to pituitary metastasis of lung cancer: case of a 21-year-old man. Intern Med 2001 0.84
28 Exposure of Caenorhabditis elegans to extremely low frequency high magnetic fields induces stress responses. Bioelectromagnetics 2001 0.83
29 Novel intravascular macromolecular MRI contrast agent with generation-4 polyamidoamine dendrimer core: accelerated renal excretion with coinjection of lysine. Magn Reson Med 2001 0.83
30 Enhancement of the therapeutic outcome of radio-immunotherapy by combination with whole-body mild hyperthermia. Eur J Cancer 2001 0.81
31 A Japanese with no detectable Rh blood group antigens due to silent Rh alleles or deleted chromosomes. Transfusion 1967 0.81
32 Myocardial bridges: a new horizon in the evaluation of ischemic heart disease. Cathet Cardiovasc Diagn 1980 0.80
33 Surgery in active infective endocarditis. Circulation 1979 0.80
34 Role of beta 2-adrenoceptor blockade and circulating adrenaline level for the pressor responses to beta-adrenoceptor blocking drugs in rats. Naunyn Schmiedebergs Arch Pharmacol 1984 0.80
35 Dynamic subtraction MR angiography: first-pass imaging of the main arteries of the lower body. AJR Am J Roentgenol 1998 0.79
36 Analysis of beta-adrenoceptors mediating renin release produced by isoproterenol in conscious dogs. Am J Physiol 1980 0.78
37 Struma ovarii: MR findings. J Comput Assist Tomogr 1997 0.78
38 Studies on agents with vasodilator and beta-blocking activities. IV. Chem Pharm Bull (Tokyo) 1996 0.76
39 Molecular genetic analysis of the Japanese amorph rh(null) phenotype. Transfusion 2000 0.75
40 Membrane proteins in Rh+, Rh- and Rh: -29, 38 (- - -/- - -, rh) red cells compared by using SDS-polyacrylamide gel electrophoresis. Comp Biochem Physiol B 1985 0.75
41 Rare Diego blood group phenotype Di(a+b-), I. Anti-Dib causing hemolytic disease of the newborn. Vox Sang 1976 0.75
42 Effects of beta-adrenoceptor blocking agents, pindolol, alprenolol and practolol on blood pressure and heart rate in conscious renal hypertensive dogs. Arch Int Pharmacodyn Ther 1977 0.75
43 The magnitude of exercise-induced ST segment depression and the predictive value of exercise testing. Clin Cardiol 1979 0.75
44 [A case of "weak A" and five cases of "weak B" blood group antigens found among the Japanese]. Nihon Hoigaku Zasshi 1965 0.75
45 Studies on agents with vasodilator and beta-blocking activities. III. Synthesis and activity of optical isomers of TZC-1370. Chem Pharm Bull (Tokyo) 1995 0.75
46 Alternaric acid stimulates phosphorylation of His-tagged RiCDPK2, a calcium-dependent protein kinase in potato plants. Genet Mol Res 2012 0.75
47 Role of beta-1 and beta-2 adrenoceptors in isoproterenol-induced renin release in conscious dogs. Life Sci 1979 0.75
48 Drug-induced inhibition of guinea pig platelet aggregation unrelated to their beta-adrenolytic actions. Jpn J Pharmacol 1983 0.75
49 [Antihypertensive action of adrenergic beta-receptor blockers and its effect on the entire sympathetic outflow in spontaneously hypertensive rats]. Nihon Yakurigaku Zasshi 1982 0.75
50 Prospective community evaluation of the signal-averaged electrocardiogram in predicting malignant ventricular arrhythmias: beneficial outcome with electrophysiology guided therapy. Clin Cardiol 1991 0.75
51 High-resolution MR cholangiopancreatography. Crit Rev Diagn Imaging 1998 0.75
52 [Clinical usefulness of fat suppression technique for MR cholangiopancreatography (MRCP)]. Nihon Rinsho 1998 0.75
53 Variability in coronary hemodynamics in response to ergonovine in patients with normal coronary arteries and atypical chest pain. J Am Coll Cardiol 1983 0.75
54 Analysis of the vasodilator action of alprenolol. Eur J Pharmacol 1978 0.75
55 Studies on agents with vasodilator and beta-blocking activities. V. Synthesis and pharmacological activity of the optical isomers of TZC-5665. Chem Pharm Bull (Tokyo) 1998 0.75
56 Recurrent catheter-induced coronary artery spasm. Cathet Cardiovasc Diagn 1977 0.75
57 Separation of strontium-89 and -90 from calcium in milk with a macrocyclic ether. Anal Chem 1979 0.75
58 Studies on agents with vasodilator and beta-blocking activities. II. Chem Pharm Bull (Tokyo) 1995 0.75
59 Antihypertensive effects of a combination of a diuretic and a beta-adrenoceptor blocking agent in conscious, renal hypertensive dogs. Jpn J Pharmacol 1978 0.75
60 Duration and selectivity in beta-adrenoceptor blocking action of a beta-adrenoceptor blocking drug, D-32 in conscious dogs. Naunyn Schmiedebergs Arch Pharmacol 1981 0.75
61 Diastolic mitral regurgitation in patients with hypertrophic cardiomyopathy. Angiology 1978 0.75
62 [MR dynamic subtraction angiography (MRDSA)]. Nihon Igaku Hoshasen Gakkai Zasshi 1997 0.75
63 Clinical significance of myocardial bridges. Am Heart J 1983 0.75
64 Different responses to beta-adrenoceptor blocking drugs of the blood pressure and heart rate in the urethane-anesthetized dog and rat. Jpn J Pharmacol 1988 0.75
65 Coronary artery spasm: an expanding role in ischemic heart disease. Tex Med 1978 0.75
66 Studies on agents with vasodilator and beta-blocking activities. I. Chem Pharm Bull (Tokyo) 1994 0.75
67 A further study on antihypertensive action of beta-adrenoceptor blocking agents in conscious, renal hypertensive dogs. Arch Int Pharmacodyn Ther 1979 0.75